The company said patients reported a 3.9 cm reduction in overall pain at three months on a 10 cm Visual Analog Scale. Patients also reported an average 4.3 cm decrease in back pain and an average 5 cm decrease in leg pain.
Results also showed that 69 percent of patients moved to a lower category on the Oswestry Disability Index and that 75 percent of patients reported being very satisfied or somewhat satisfied with their therapy at three months.
The results are consistent with a previous study conducted by Medtronic, the company said.
